Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome
City of Hope Medical Center
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
Allogene Therapeutics
Medical College of Wisconsin
Novartis
Dartmouth-Hitchcock Medical Center
Second Xiangya Hospital of Central South University
H. Lee Moffitt Cancer Center and Research Institute
Amgen
Aarhus University Hospital
MedSIR
University of Oklahoma
UNC Lineberger Comprehensive Cancer Center
Tempus AI
Peking University People's Hospital
Eastern Cooperative Oncology Group
PETHEMA Foundation
M.D. Anderson Cancer Center
Peking University People's Hospital
Sun Yat-sen University